COLLABORATIONS
NAME AFFILIATION Project State
HOLME Jorn Norvegian Institute of Public Health, Oslo, Norway HAPs and lipid accumulation 2009, 2011
STIEGER Bruno Division of Clinical Pharmacology and Toxicology, Zurich, Switzerland Membrane transporters 2008, 2009, 2009, 2011,
KRONENBERG Florian Division of Genetic Epidemiology, Department of Medical Genetics, Innsbruck Medical University, Innsbruck, Austria Lp(a) and chemokine CCL1 2009
GORDON, John Immunology Research group, Saskatchewan, Canada CXCR1/CXCR2 receptors 2008
LEVOIN Nicolas Laboratoire Bioprojet, Rennes HAPs and beta2-adrenergic receptor ongoing
URIAC Philippe UMR CNRS 6226, Faculté de Pharmacie, Rennes HAPs and beta2-adrenergic receptor ongoing
DESMOTS sophie Unité de Toxicologie expérimentale, INERIS, Verneuil-en-Halatte Exposure assessment and biomarkers ongoing 2009, 2010, 2011, 2011
PERY Alexandre Unité METO, INERIS, Verneuil-en-Halatte Exposure assessment and biomarkers ongoing 2010, 2011
PALLARDY Marc INSERM UMR 996, Faculté de Pharmacie Paris XI, Châtenay-Malabry Arsenic and Dendritic cells ongoing
KERDINE-ROMER Saadia INSERM UMR 996, Faculté de Pharmacie Paris XI, Châtenay-Malabry Arsenic and Dendritic cells ongoing
COURTOIS Arnaud INSERM 885, Bordeaux HAPs and beta2-adrenergic receptor ongoing
RIOUX Vincent INRA-Agrocampus ouest, Rennes Lipid analysis 2011
RIALLAND Mickael Centre de recherche INSERM, UMR866, Dijon Lipid homeostasis 2011